Omnicell Inc. | Small-cap | Healthcare
$29.84
0.13%
| Omnicell Stock Comparison:
Omnicell vs Veeva SystemsOmnicell vs Ge HealthcareOmnicell vs PremierOmnicell vs CertaraOmnicell vs SchrodingerOmnicell vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.1B
Gross Profit 471.0M 42.35%
Operating Income 337.0K 0.03%
Net Income 12.5M 1.13%

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 877.6M
Shareholders Equity 1.2B
Debt to Equity 0.71

Cash Flow Metrics

Operating Cash Flow 168.6M
Free Cash Flow 134.9M

Revenue & Profitability Trend

Omnicell Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue1.1B1.1B1.3B1.1B892.2M
Cost of Goods Sold641.2M650.3M707.0M577.4M478.9M
Gross Profit471.0M496.8M589.0M554.7M413.3M
Operating Expenses470.7M531.7M591.3M465.1M377.8M
Operating Income337.0K-34.9M-2.3M89.5M35.5M
Pre-tax Income25.6M-20.1M-2.5M66.0M29.3M
Income Tax13.1M263.0K-8.1M-11.8M-2.8M
Net Income12.5M-20.4M5.6M77.8M32.2M
EPS (Diluted)--$0.45$0.12$1.62$0.74

Income Statement Trend

Omnicell Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets815.5M927.6M881.8M780.7M829.4M
Non-Current Assets1.3B1.3B1.3B1.4B995.1M
Total Assets2.1B2.2B2.2B2.1B1.8B
Liabilities
Current Liabilities595.7M367.8M428.4M876.2M276.4M
Non-Current Liabilities282.0M670.1M652.2M119.6M580.6M
Total Liabilities877.6M1.0B1.1B995.8M857.0M
Equity
Total Shareholders Equity1.2B1.2B1.1B1.1B967.5M

Balance Sheet Composition

Omnicell Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income12.5M-20.4M5.6M77.8M32.2M
Operating Cash Flow168.6M191.1M47.7M196.8M191.4M
Investing Activities
Capital Expenditures-36.5M-41.5M-47.5M-29.0M-22.8M
Investing Cash Flow-36.5M-41.5M-45.5M-383.1M-247.8M
Financing Activities
Dividends Paid-----
Financing Cash Flow-274.2M204.0K-61.1M-20.0M150.7M
Free Cash Flow134.9M126.1M17.0M173.5M131.0M

Cash Flow Trend

Omnicell Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 61.67
Forward P/E 15.76
Price to Book 1.06
Price to Sales 1.17
PEG Ratio 15.76

Profitability Ratios

Profit Margin 1.87%
Operating Margin -4.31%
Return on Equity 1.73%
Return on Assets 0.35%

Financial Health

Current Ratio 1.38
Debt to Equity 30.69
Beta 0.78

Per Share Data

EPS (TTM) $0.46
Book Value per Share $26.84
Revenue per Share $24.55

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
omcl1.3B61.671.061.73%1.87%30.69
Veeva Systems 46.0B59.927.3914.06%27.34%1.24
Ge Healthcare 32.6B14.953.5526.44%11.03%97.52
Premier 1.9B21.461.186.85%4.96%19.35
Certara 1.7B104.001.56-0.25%-0.67%28.51
Schrodinger 1.5B44.394.05-43.33%-83.39%31.15

Financial data is updated regularly. All figures are in the company's reporting currency.